Results 141 to 150 of about 11,732 (171)

Real-world effectiveness of NALIRIFOX versus modified FOLFIRINOX or gemcitabine and nab-paclitaxel in first-line advanced pancreatic adenocarcinoma: a multicentre propensity-matched study. [PDF]

BMJ Oncol
Thambamroong T, Meesart R, Prasongsook N, Ngamphaiboon N, Akewanlop C, Tanasanvimon S, Phavirunsiri J, Pakvisal N, Korphaisarn K, Sathitruangsak C, Siripoon T, Simseekeaw P, Charonpongsuntorn C, Wirasorn K, Kerkarchachai G, Eiamprapaporn P, Suksombooncharoen T, Sa-Nguansai S, Patiluntakankul A, Sirachainan E.   +19 more
europepmc   +1 more source

Beyond Morphology: Molecular Evidence Supporting a Clonal Relationship Between Pancreatic Undifferentiated Carcinoma with Osteoclast-like Giant Cells (UCOGC) and Conventional Pancreatic Ductal Adenocarcinoma (PDAC). [PDF]

Cancers (Basel)
Marginean EC, Dhaliwal D, Fisher KE, Italiya S, Dema A.   +4 more
europepmc   +1 more source

Case Report: long complete metabolic response assessed by LAFOV FDG-PET/CT to FOLFIRINOX in first-line treatment of metastatic low-differentiated pancreatic carcinoma. [PDF]

Front Med (Lausanne)
Abgral R, Dzuko Kamga J, Metges JP, Salaun PY.   +3 more
europepmc   +1 more source

Transarterial infusion chemotherapy combined with lenvatinib and tislelizumab versus intravenous chemotherapy for unresectable pancreatic ductal adenocarcinoma: a retrospective propensity score matching analysis. [PDF]

Front Oncol
Lu H, Liang B, Fu Q, Xia X.
europepmc   +1 more source

Apparent Long-Term Cure Following Conversion Therapy for Initially Unresectable Pancreatic Ductal Adenocarcinoma: A Case Report. [PDF]

Cureus
Florou E, Zen Y, Srinivasan P, Prachalias A.   +3 more
europepmc   +1 more source

Pathologic Complete Response to Modified FOLFIRINOX Enabling Conversion Surgery in Pancreatic Acinar Cell Carcinoma on Hemodialysis: A Case Report. [PDF]

Surg Case Rep
Sekine K, Takeda Y, Takahashi A, Irie S, Hirata Y, Kato T, Yoshioka R, Kotera Y, Mise Y, Saiura A.   +9 more
europepmc   +1 more source

Survival after resection of pancreatic cancer is similar with neoadjuvant gemcitabine-nab-paclitaxel or mFOLFIRINOX but one size will not fit all in the future. [PDF]

Hepatobiliary Surg Nutr
Hernandez S, Maker AV.
europepmc   +1 more source

Molecular Characterization of Small Extracellular Vesicles in Pancreatic Cancer Patients Treated with Neoadjuvant Chemotherapy Followed by Stereotactic Body Radiation. [PDF]

Cancers (Basel)
Paluri RK, Kumar A, Su Y, Singh S, Gbolahan OB, Manne A, Manne U, Deep G.   +7 more
europepmc   +1 more source

Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma. [PDF]

J Exp Clin Cancer Res
Zambalde EP, Ariyan LA, Puerta-Martinez F, Zhu YQ, Patil P, Panarelli NC, Li J, Jung Y, Adkisson C, Petersen J, Cox D, Gil-Henn H, Eddy R, Stanger BZ, Entenberg D, Oktay MH, Condeelis JS, McAuliffe JC.   +17 more
europepmc   +1 more source